NeuroOne Medical Technologies Corporation Stock
Equities
NMTC
US64130M2098
Advanced Medical Equipment & Technology
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.16 USD | +3.57% | -4.13% | -26.58% |
Financials (USD)
Sales 2022 | 2.12 | Sales 2023 | 3.41 | Capitalization | 21.3M |
---|---|---|---|---|---|
Net income 2022 | -10M | Net income 2023 | -11M | EV / Sales 2022 | 7,761,717 x |
Net cash position 2022 | 10.94M | Net cash position 2023 | 5.14M | EV / Sales 2023 | 4,742,168 x |
P/E ratio 2022 |
-2.7
x | P/E ratio 2023 |
-1.36
x | Employees | 16 |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 87.91% |
Latest transcript on NeuroOne Medical Technologies Corporation
1 day | +3.57% | ||
1 week | -4.13% | ||
Current month | +2.65% | ||
1 month | -8.66% | ||
3 months | -20.00% | ||
6 months | -7.20% | ||
Current year | -26.58% |
Managers | Title | Age | Since |
---|---|---|---|
Mark Christanson
FOU | Founder | 56 | 09-08-19 |
David Rosa
CEO | Chief Executive Officer | 59 | 17-07-19 |
Ronald McClurg
DFI | Director of Finance/CFO | 65 | 20-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Paul Buckman
CHM | Chairman | 68 | 17-08-03 |
Director/Board Member | 63 | 17-08-03 | |
Edward Andrle
BRD | Director/Board Member | 66 | 20-02-17 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-09 | 1.16 | +3.57% | 92,038 |
24-05-08 | 1.12 | -4.27% | 154,895 |
24-05-07 | 1.17 | 0.00% | 829,308 |
24-05-06 | 1.17 | 0.00% | 45,824 |
24-05-03 | 1.17 | -3.31% | 41,007 |
Delayed Quote Nasdaq, May 09, 2024 at 04:00 pm EDT
More quotes1st Jan change | Capi. | |
---|---|---|
-26.58% | 29.04M | |
-15.43% | 18.51B | |
-40.81% | 2.85B | |
+19.34% | 1.95B | |
+2.22% | 1.72B | |
+28.27% | 1.26B | |
-9.56% | 1.02B | |
-16.29% | 950M | |
+0.07% | 777M | |
-22.49% | 643M |
- Stock Market
- Equities
- NMTC Stock